Hims & Hers Health Inc

HIMS

Company Profile

  • Business description

    Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.

  • Contact

    2269 Chestnut Street
    Suite 523
    San FranciscoCA94123
    USA

    T: +1 415 851-0195

    https://www.forhims.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    1,637

Stocks News & Analysis

stocks

Apple: Gemini partnership lets AI-worried investors breathe a sigh of relief

We believe a competitive—if not leading—AI feature suite will reinforce Apple’s wide-moat mobile device ecosystem.
stocks

ASX share ticks all the popular thematic boxes

The shares are overvalued as investors are overly excited about defence and gold exposure.
stocks

Bluescope offer knocked back by board

Our view on the potential for additional offers.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,171.3044.200.48%
CAC 408,358.763.33-0.04%
DAX 4025,405.34143.700.57%
Dow JONES (US)49,590.2086.130.17%
FTSE 10010,140.7016.100.16%
HKSE27,082.79474.311.78%
NASDAQ23,733.9062.560.26%
Nikkei 22553,652.381,712.493.30%
NZX 50 Index13,634.2049.09-0.36%
S&P 5006,977.2710.990.16%
S&P/ASX 2008,840.7049.400.56%
SSE Composite Index4,174.309.020.22%

Market Movers